Eucrisa OverviewCrisaborole (INN, USAN, trade name Eucrisa ew-KRIS-, codenamed AN2728) is a non-steroidal, topical medication approved for the treatment of mild-to-moderate atopic dermatitis (eczema) in patients 2 years of age and older. As of 2016[update] it is also under development by Anacor Pharmaceuticals for the topical treatment of psoriasis. Contents 1 Mechanism of action 2 Clinical trials 3 See also 4 References Mechanism of action It is a phosphodiesterase-4 inhibit...
Read more Eucrisa Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Crisaborole
Recent Eucrisa Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Ointment: 2%